BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9816024)

  • 1. Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123.
    Wong JR; Ho C; Mauch P; Coleman N; Berman S; Chen LB
    Clin Cancer Res; 1995 Jun; 1(6):621-30. PubMed ID: 9816024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity.
    Sun X; Wong JR; Song K; Hu J; Garlid KD; Chen LB
    Cancer Res; 1994 Mar; 54(6):1465-71. PubMed ID: 8137249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine.
    Schneiderman MH; Jackson JD; Joshi SS; Clark-Pierce L; Murphy BJ; Schneiderman GS
    Radiat Res; 1998 Feb; 149(2):147-54. PubMed ID: 9457894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel HSV-1 virus, JS1/34.5-/47-, purges contaminating breast cancer cells from bone marrow.
    Hu JC; Booth MJ; Tripuraneni G; Davies D; Zaidi SA; Tamburo de Bella M; Slade MJ; Marley SB; Gordon MY; Coffin RS; Coombes RC; Kamalati T
    Clin Cancer Res; 2006 Nov; 12(22):6853-62. PubMed ID: 17121907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.
    Huang HF; Chen YZ; Wu Y; Chen P
    Bone Marrow Transplant; 2006 Jan; 37(2):213-7. PubMed ID: 16284611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
    Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
    Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and application of a murine transplant model of bone marrow purging of metastatic breast cancer cells in vitro].
    Hu ZP; Liu WL; Stuart B; Zhang YC
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):621-3. PubMed ID: 18246821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
    Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
    Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
    Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
    Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies 2-Butoxyethanol (CAS NO. 111-76-2) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Mar; 484():1-290. PubMed ID: 12571679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines.
    Gordon LI; Rosen ST; Vriesendorp HM; Kies MS; Kucuk O
    Cancer Res; 1984 Nov; 44(11):5404-8. PubMed ID: 6091877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative selection and protection of normal progenitor cells for autografting.
    Douay L
    Bone Marrow Transplant; 1998 Sep; 22(5):423-30. PubMed ID: 9733264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.